The Role of Immune Checkpoints in Lung Transplant (ILTRA) (ILTRA)
The Role of Immune Checkpoints in Lung Transplant: the Pathways of Rejection and the Immunomodulatory Therapeutic Perspectives
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
This observational or N/A phase trial investigates Lung Transplant Rejection and is currently ongoing. Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Mar 2026 — Present [monthly]
Unknown
Status: Not Yet Recruiting → Unknown
-
Sep 2025 — Mar 2026 [monthly]
Not Yet Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- University of Milan
- University of Padova
- University of Turin, Italy
For direct contact, visit the study record on ClinicalTrials.gov .